Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement
Vasileios Chortis, Angela E Taylor, Petra Schneider, Jeremy W Tomlinson, Beverly A Hughes, Donna M O'Neil, Rossella Libé, Bruno Allolio, Xavier Bertagna, Jérôme Bertherat, Felix Beuschlein, Martin Fassnacht, Niki Karavitaki, Massimo Mannelli, Franco Mantero, Giuseppe Opocher, Emilio Porfiri, Marcus Quinkler, Mark Sherlock, Massimo TerzoloPeter Nightingale, Cedric H L Shackleton, Paul M Stewart, Stefanie Hahner, Wiebke Arlt
Research output: Contribution to journal › Article › peer-review
90Citations
(Scopus)
697Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement'. Together they form a unique fingerprint.